Published in Anal Biochem on April 02, 2007
Measuring proteome dynamics in vivo: as easy as adding water? Mol Cell Proteomics (2009) 1.39
Measuring protein synthesis using metabolic ²H labeling, high-resolution mass spectrometry, and an algorithm. Anal Biochem (2011) 1.16
Kinetic isotope effects for RNA cleavage by 2'-O- transphosphorylation: nucleophilic activation by specific base. J Am Chem Soc (2010) 1.07
Isotopologue distributions of peptide product ions by tandem mass spectrometry: quantitation of low levels of deuterium incorporation. Anal Biochem (2007) 0.94
Applications of metabolomics and proteomics to the mdx mouse model of Duchenne muscular dystrophy: lessons from downstream of the transcriptome. Genome Med (2009) 0.87
Experimental analyses of the chemical dynamics of ribozyme catalysis. Curr Opin Chem Biol (2008) 0.82
Determination of relative rate constants for in vitro RNA processing reactions by internal competition. Anal Biochem (2014) 0.82
Ab initio path-integral calculations of kinetic and equilibrium isotope effects on base-catalyzed RNA transphosphorylation models. J Comput Chem (2014) 0.77
Investigation of the mechanism of the SpnF-catalyzed [4+2]-cycloaddition reaction in the biosynthesis of spinosyn A. Proc Natl Acad Sci U S A (2017) 0.75
Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat Biotechnol (1999) 21.92
Determining the chemical mechanisms of enzyme-catalyzed reactions by kinetic studies. Adv Enzymol Relat Areas Mol Biol (1977) 2.62
Measurement of protein turnover rates by heavy water labeling of nonessential amino acids. Biochim Biophys Acta (2006) 2.04
Measurement of very low stable isotope enrichments by gas chromatography/mass spectrometry: application to measurement of muscle protein synthesis. Metabolism (1997) 1.61
Enzymatic transition states and transition state analog design. Annu Rev Biochem (1998) 1.48
The use of isotope effects to determine enzyme mechanisms. Arch Biochem Biophys (2005) 1.42
Analysis of solvent nucleophile isotope effects: evidence for concerted mechanisms and nucleophilic activation by metal coordination in nonenzymatic and ribozyme-catalyzed phosphodiester hydrolysis. Biochemistry (2004) 1.28
Determination of heavy-atom isotope effects on enzyme-catalyzed reactions. Methods Enzymol (1980) 1.25
Transition State Structure for the Hydrolysis of NAD Catalyzed by Diphtheria Toxin. J Am Chem Soc (1997) 1.20
Enzymatic transition-state analysis and transition-state analogs. Methods Enzymol (1999) 1.19
Is there hydrogen scrambling in the gas phase? Energetic and structural determinants of proton mobility within protein ions. J Am Chem Soc (2004) 1.18
Identification of the sites of hydroxyl radical reaction with peptides by hydrogen/deuterium exchange: prevalence of reactions with the side chains. Biochemistry (2000) 1.15
Measuring protein synthesis by mass isotopomer distribution analysis (MIDA). Anal Biochem (1999) 1.13
Evidence for direct attack by hydroxide in phosphodiester hydrolysis. J Am Chem Soc (2002) 1.12
Kinetic isotope effect analysis of the ribosomal peptidyl transferase reaction. Biochemistry (2005) 1.09
Identification of individual nucleotides in the bacterial ribonuclease P ribozyme adjacent to the pre-tRNA cleavage site by short-range photo-cross-linking. Biochemistry (1998) 1.06
Computing positional isotopomer distributions from tandem mass spectrometric data. Metab Eng (2002) 1.06
Crotonase-catalyzed beta-elimination is concerted: a double isotope effect study. Biochemistry (1991) 1.01
13C isotopomer analysis of glutamate by tandem mass spectrometry. Anal Biochem (2002) 0.96
Conservation of helical structure contributes to functional metal ion interactions in the catalytic domain of ribonuclease P RNA. J Mol Biol (2002) 0.96
Isotopologue distributions of peptide product ions by tandem mass spectrometry: quantitation of low levels of deuterium incorporation. Anal Biochem (2007) 0.94
Measuring gluconeogenesis using a low dose of 2H2O: advantage of isotope fractionation during gas chromatography. Am J Physiol Endocrinol Metab (2003) 0.92
Determination of amino acid isotope enrichment using liquid chromatography-mass spectrometry. Anal Biochem (1999) 0.90
Effect of pressure on a heavy-atom isotope effect of yeast alcohol dehydrogenase. J Am Chem Soc (2006) 0.88
Measuring synthesis rates of muscle creatine kinase and myosin with stable isotopes and mass spectrometry. Anal Biochem (2002) 0.88
Liquid chromatography/mass spectrometry of plasma glucose and secreted glucuronate for metabolic studies in humans. Biomed Environ Mass Spectrom (1990) 0.86
Acid hydrolysis of silk fibroins and determination of the enrichment of isotopically labeled amino acids using precolumn derivatization and high-performance liquid chromatography-electrospray ionization-mass spectrometry. Anal Biochem (2002) 0.84
Assessment of nitric oxide production by measurement of [15N]citrulline enrichment in human plasma using high-performance liquid chromatography-mass spectrometry. Anal Biochem (1998) 0.79
Letter: Kinetic isotope effects for the chymotrypsin catalyzed hydrolysis of ethoxyl-18 O labeled specific ester substrates. J Am Chem Soc (1975) 0.79
Quantitation of metal isotope ratios by laser desorption time-of-flight mass spectrometry. Anal Chem (1995) 0.78
Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism. N Engl J Med (2003) 8.55
Comparison of 10-mg and 5-mg warfarin initiation nomograms together with low-molecular-weight heparin for outpatient treatment of acute venous thromboembolism. A randomized, double-blind, controlled trial. Ann Intern Med (2003) 8.33
Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis. N Engl J Med (2003) 7.15
Do workplace health promotion (wellness) programs work? J Occup Environ Med (2014) 3.80
Comparing the quality of oral anticoagulant management by anticoagulation clinics and by family physicians: a randomized controlled trial. CMAJ (2003) 3.73
Randomized placebo-controlled study of low-dose warfarin for the prevention of central venous catheter-associated thrombosis in patients with cancer. J Clin Oncol (2005) 2.53
Regulation of NF-kappaB by NSD1/FBXL11-dependent reversible lysine methylation of p65. Proc Natl Acad Sci U S A (2009) 2.10
Reversible methylation of promoter-bound STAT3 by histone-modifying enzymes. Proc Natl Acad Sci U S A (2010) 2.06
Exploring the role of a conserved class A residue in the Ω-Loop of KPC-2 β-lactamase: a mechanism for ceftazidime hydrolysis. J Biol Chem (2012) 1.93
Metal binding and oxidation of amyloid-beta within isolated senile plaque cores: Raman microscopic evidence. Biochemistry (2003) 1.89
Identification of a new allelic variant of the Acinetobacter baumannii cephalosporinase, ADC-7 beta-lactamase: defining a unique family of class C enzymes. Antimicrob Agents Chemother (2005) 1.88
An evaluation of D-dimer in the diagnosis of pulmonary embolism: a randomized trial. Ann Intern Med (2006) 1.78
A randomized trial comparing 2 low-molecular-weight heparins for the outpatient treatment of deep vein thrombosis and pulmonary embolism. Arch Intern Med (2005) 1.75
3-nitropropionic acid is a suicide inhibitor of mitochondrial respiration that, upon oxidation by complex II, forms a covalent adduct with a catalytic base arginine in the active site of the enzyme. J Biol Chem (2005) 1.75
Structures of rhodopsin kinase in different ligand states reveal key elements involved in G protein-coupled receptor kinase activation. J Biol Chem (2008) 1.62
A wake-up call for corporate America. J Occup Environ Med (2003) 1.48
Malaria parasite invasion of the mosquito salivary gland requires interaction between the Plasmodium TRAP and the Anopheles saglin proteins. PLoS Pathog (2009) 1.44
Understanding resistance to beta-lactams and beta-lactamase inhibitors in the SHV beta-lactamase: lessons from the mutagenesis of SER-130. J Biol Chem (2003) 1.41
Measuring proteome dynamics in vivo: as easy as adding water? Mol Cell Proteomics (2009) 1.39
Review of the studies cited in the DataBase section of the American Journal of Health Promotion. Am J Health Promot (2004) 1.38
Clavulanic acid inactivation of SHV-1 and the inhibitor-resistant S130G SHV-1 beta-lactamase. Insights into the mechanism of inhibition. J Biol Chem (2005) 1.37
Rational design of a beta-lactamase inhibitor achieved via stabilization of the trans-enamine intermediate: 1.28 A crystal structure of wt SHV-1 complex with a penam sulfone. J Am Chem Soc (2006) 1.36
A high C/O ratio and weak thermal inversion in the atmosphere of exoplanet WASP-12b. Nature (2010) 1.34
Inhibition of class A beta-lactamases by carbapenems: crystallographic observation of two conformations of meropenem in SHV-1. J Am Chem Soc (2008) 1.32
Analysis of solvent nucleophile isotope effects: evidence for concerted mechanisms and nucleophilic activation by metal coordination in nonenzymatic and ribozyme-catalyzed phosphodiester hydrolysis. Biochemistry (2004) 1.28
Structural mechanism of enoyl-CoA hydratase: three atoms from a single water are added in either an E1cb stepwise or concerted fashion. Biochemistry (2002) 1.26
Productive folding to the native state by a group II intron ribozyme. J Mol Biol (2002) 1.26
Evidence that substrate-specific effects of C5 protein lead to uniformity in binding and catalysis by RNase P. EMBO J (2006) 1.24
Role of Asp104 in the SHV beta-lactamase. Antimicrob Agents Chemother (2006) 1.21
Amino acid substitutions at Ambler position Gly238 in the SHV-1 beta-lactamase: exploring sequence requirements for resistance to penicillins and cephalosporins. Antimicrob Agents Chemother (2002) 1.20
Recognition of the 5' leader of pre-tRNA substrates by the active site of ribonuclease P. RNA (2003) 1.19
Secondary structure of alpha-synuclein oligomers: characterization by raman and atomic force microscopy. J Mol Biol (2005) 1.19
Evidence for a tyrosine-adenine stacking interaction and for a short-lived open intermediate subsequent to initial binding of Escherichia coli RNA polymerase to promoter DNA. J Mol Biol (2008) 1.17
PRMT5 dimethylates R30 of the p65 subunit to activate NF-κB. Proc Natl Acad Sci U S A (2013) 1.17
Measuring protein synthesis using metabolic ²H labeling, high-resolution mass spectrometry, and an algorithm. Anal Biochem (2011) 1.16
Raman spectroscopic characterization of secondary structure in natively unfolded proteins: alpha-synuclein. J Am Chem Soc (2004) 1.15
Hidden specificity in an apparently nonspecific RNA-binding protein. Nature (2013) 1.13
Evidence for direct attack by hydroxide in phosphodiester hydrolysis. J Am Chem Soc (2002) 1.12
A benzothiophene inhibitor of mitogen-activated protein kinase-activated protein kinase 2 inhibits tumor necrosis factor alpha production and has oral anti-inflammatory efficacy in acute and chronic models of inflammation. J Pharmacol Exp Ther (2010) 1.10
Catalase abrogates β-lapachone-induced PARP1 hyperactivation-directed programmed necrosis in NQO1-positive breast cancers. Mol Cancer Ther (2013) 1.08
The role of incentive design, incentive value, communications strategy, and worksite culture on health risk assessment participation. Am J Health Promot (2009) 1.08
Metabolomic and mass isotopomer analysis of liver gluconeogenesis and citric acid cycle: II. Heterogeneity of metabolite labeling pattern. J Biol Chem (2008) 1.08
Conformational dynamics of activation for the pentameric complex of dimeric G protein-coupled receptor and heterotrimeric G protein. Structure (2012) 1.07
Kinetic isotope effects for RNA cleavage by 2'-O- transphosphorylation: nucleophilic activation by specific base. J Am Chem Soc (2010) 1.07
Strategic design of an effective beta-lactamase inhibitor: LN-1-255, a 6-alkylidene-2'-substituted penicillin sulfone. J Biol Chem (2008) 1.07
Chaperone peptides of α-crystallin inhibit epithelial cell apoptosis, protein insolubilization, and opacification in experimental cataracts. J Biol Chem (2013) 1.05
Experimental and computational analysis of the transition state for ribonuclease A-catalyzed RNA 2'-O-transphosphorylation. Proc Natl Acad Sci U S A (2013) 1.05
Plasma proteome dynamics: analysis of lipoproteins and acute phase response proteins with 2H2O metabolic labeling. Mol Cell Proteomics (2012) 1.05
Dynamics of glutathione and ophthalmate traced with 2H-enriched body water in rats and humans. Am J Physiol Endocrinol Metab (2009) 1.05
Inhibition of OXA-1 beta-lactamase by penems. Antimicrob Agents Chemother (2008) 1.04
Evidence for a polynuclear metal ion binding site in the catalytic domain of ribonuclease P RNA. EMBO J (2002) 1.03
Localization of fatty acyl and double bond positions in phosphatidylcholines using a dual stage CID fragmentation coupled with ion mobility mass spectrometry. J Am Soc Mass Spectrom (2011) 1.03
Different properties of the native and reconstituted heterotrimeric G protein transducin. Biochemistry (2008) 1.03
Metabolomic and mass isotopomer analysis of liver gluconeogenesis and citric acid cycle. I. Interrelation between gluconeogenesis and cataplerosis; formation of methoxamates from aminooxyacetate and ketoacids. J Biol Chem (2008) 1.03
Influence of thrombophilia on risk of recurrent venous thromboembolism while on warfarin: results from a randomized trial. Blood (2008) 1.03
Triclosan inhibits enoyl-reductase of type I fatty acid synthase in vitro and is cytotoxic to MCF-7 and SKBr-3 breast cancer cells. Cancer Chemother Pharmacol (2002) 1.02
Linking Workplace Health Promotion Best Practices and Organizational Financial Performance: Tracking Market Performance of Companies With Highest Scores on the HERO Scorecard. J Occup Environ Med (2016) 1.02
Characterization of the reaction path and transition states for RNA transphosphorylation models from theory and experiment. Angew Chem Int Ed Engl (2011) 1.02
Catheter-associated thrombosis in patients with malignancy. J Clin Oncol (2009) 1.00
Evidence that binding of C5 protein to P RNA enhances ribozyme catalysis by influencing active site metal ion affinity. RNA (2007) 1.00
Analysis of substrate recognition by the ribonucleoprotein endonuclease RNase P. Methods (2002) 1.00
Pre-steady-state and stopped-flow fluorescence analysis of Escherichia coli ribonuclease III: insights into mechanism and conformational changes associated with binding and catalysis. J Mol Biol (2002) 0.99
Protein-precursor tRNA contact leads to sequence-specific recognition of 5' leaders by bacterial ribonuclease P. J Mol Biol (2009) 0.99
Interpretation of V/K isotope effects for enzymatic reactions exhibiting multiple isotopically sensitive steps. J Theor Biol (2006) 0.98
Covalent cross-linking of glutathione and carnosine to proteins by 4-oxo-2-nonenal. Chem Res Toxicol (2009) 0.98
Antihypertensive efficacy, safety, and tolerability of the oral direct renin inhibitor aliskiren in patients with hypertension: a pooled analysis. J Am Soc Hypertens (2010) 0.98
The pre-tRNA nucleotide base and 2'-hydroxyl at N(-1) contribute to fidelity in tRNA processing by RNase P. J Mol Biol (2004) 0.98
Characterization of the Structure and Dynamics of the HDV Ribozyme at Different Stages Along the Reaction Path. J Phys Chem Lett (2011) 0.98
Structure-based mapping of DAF active site residues that accelerate the decay of C3 convertases. J Biol Chem (2007) 0.97
Conservation of helical structure contributes to functional metal ion interactions in the catalytic domain of ribonuclease P RNA. J Mol Biol (2002) 0.96
Effectiveness of a worksite telephone-based weight management program. Am J Health Promot (2011) 0.95
Isotopologue distributions of peptide product ions by tandem mass spectrometry: quantitation of low levels of deuterium incorporation. Anal Biochem (2007) 0.94
The relationship between health promotion program participation and medical costs: a dose response. J Occup Environ Med (2003) 0.94
Acetylation of αA-crystallin in the human lens: effects on structure and chaperone function. Biochim Biophys Acta (2011) 0.94
Exploring the Role of Residue 228 in Substrate and Inhibitor Recognition by VIM Metallo-β-lactamases. Biochemistry (2015) 0.93
Hybrid procedure as an alternative to surgical palliation of high-risk infants with hypoplastic left heart syndrome and its variants. J Thorac Cardiovasc Surg (2010) 0.93
The P4 metal binding site in RNase P RNA affects active site metal affinity through substrate positioning. RNA (2006) 0.93
Impact of financial incentives on behavior change program participation and risk reduction in worksite health promotion. Am J Health Promot (2012) 0.93
Mass isotopomer study of anaplerosis from propionate in the perfused rat heart. Arch Biochem Biophys (2007) 0.93
Penicillin sulfone inhibitors of class D beta-lactamases. Antimicrob Agents Chemother (2010) 0.93
Binding of C5 protein to P RNA enhances the rate constant for catalysis for P RNA processing of pre-tRNAs lacking a consensus (+ 1)/C(+ 72) pair. J Mol Biol (2009) 0.93
Novel tetrahydro-beta-carboline-1-carboxylic acids as inhibitors of mitogen activated protein kinase-activated protein kinase 2 (MK-2). Bioorg Med Chem Lett (2007) 0.93
Intravenous immunoglobulin utilization in the Canadian Atlantic provinces: a report of the Atlantic Collaborative Intravenous Immune Globulin Utilization Working Group. Transfusion (2007) 0.92
Posttranslational modifications of the photoreceptor-specific ABC transporter ABCA4. Biochemistry (2011) 0.92
NAIM and site-specific functional group modification analysis of RNase P RNA: magnesium dependent structure within the conserved P1-P4 multihelix junction contributes to catalysis. Biochemistry (2002) 0.92
Oxidative modification of cytochrome c by singlet oxygen. Free Radic Biol Med (2008) 0.92
Measuring gluconeogenesis using a low dose of 2H2O: advantage of isotope fractionation during gas chromatography. Am J Physiol Endocrinol Metab (2003) 0.92
Oxygen-coupled redox regulation of the skeletal muscle ryanodine receptor/Ca2+ release channel (RyR1): sites and nature of oxidative modification. J Biol Chem (2013) 0.92
Presenteeism according to healthy behaviors, physical health, and work environment. Popul Health Manag (2012) 0.91
RNA-dependent folding and stabilization of C5 protein during assembly of the E. coli RNase P holoenzyme. J Mol Biol (2006) 0.91
A functional kinase homology domain is essential for the activity of photoreceptor guanylate cyclase 1. J Biol Chem (2009) 0.91
Cardiolipin: characterization of distinct oxidized molecular species. J Lipid Res (2010) 0.91